Chanarin-Dorfman syndrome

Chanarin-Dorfman syndrome is also known as neutral lipid storage disease with ichthyosis. Clinically, it is an autosomal recessive form of non-bullous congenital ichthyosiform eryhthroderma (NCIE), demonstrating fine white scaling on an erythematous background. Babies with Chanarin-Dorfman may be born with a collodion membrane, and cases have been reported with bilateral ectropion and eclabion. Hair, nails, teeth, and mucosa are normal. In addition to NCIE, however, affected individuals have other organ involvement, the most frequent of which is hepatomegaly and liver steatosis. Muscle weakness, ataxia, neurosensory hearing loss, eye findings (subcapsular cataracts, nystagmus and strabismus), and mental retardation may also be present. Histologically, intracellular lipid droplets are found in most tissues and confirmation of the diagnosis can be made on a peripheral blood smear to evaluate the presence of these lipid vacuoles in granulocytes.

Tests Available

Forms and Documents

Test Details

ABCA12, ABHD5, AGPS, ALDH3A2, ALOX12B, ALOXE3, AP1S1, ARSE, CASP14, CERS3, CLDN1, CYP4F22, EBP, ELOVL4, FLG, GJB2 (Cx26), GJB3 (Cx31), GJB4 (Cx30.3), GJB6 (Cx30), KRT1, KRT10, KRT2, KRT9, LIPN, LOR, NIPAL4(Ichthyin), PEX7, PHGDH, PHYH, PNPLA1, PNPLA2, POMP, PSAT1, SDR9C7, SLC27A4, SNAP29, SPINK5, ST14, STS, TGM1, TGM5, VPS33B, ZMPSTE24
  • Identification of the specific molecular basis of congential ichthyosis or related skin disorders
  • Genetic counseling and recurrence risk assessment
  • Option for prenatal testing in future pregnancies

As needed, based on the referring diagnosis and coverage achieved by the XomeDxSlice-Ichthyosis for a given patient, critical exons with a high yield of mutations will be filled-in by dideoxy sequencing. For any autosomal recessive gene, if one definitive mutation is found by XomeDxSlice sequencing, AND the gene fits the type of ichthyosis reported by the referring physician, capillary sequencing will be used to fill in sequence for exons that are not sufficiently covered (>10X) to find the second mutation. If no second mutation is found by sequencing, deletion/duplication analysis of that gene can be performed at no additional cost can be performed at no additional cost.

Patient samples sent for XomeDxSlice will not be evaluated for secondary findings and therefore will not receive secondary findings as part of their result.\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"

  • Next-Gen Sequencing

Ordering

708
6 weeks
2-5 mL Blood - Lavender Top Tube
Oral Rinse (30-40 mL)|Dried Blood Spots|Buccal Swabs

Billing

81252x1, 81254x1, 81401x1, 81479x1
Yes
Yes
* For price inquiries please email zebras@genedx.com